Before revision: Regulation Most developed nations require generic drug manufacturers to prove that their formulations are bioequivalent to their brand-name counterparts.
After revision: Gooo kha Most developed nations require generic drug manufacturers to prove that their formulations are bioequivalent to their brand-name counterparts.